301 BINNEY STREET, CAMBRIDGE, MA
Investor Presentation
Annual Report to Security Holders
Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
Earnings Release
Amended material disclosure
Other Events
Scholar Rock Holding Corporation Files Prospectus Supplement for ATM Program
Q1
FY 2025
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
Correspondence
Submission Upload